In this study, we designed a self-assembling RNA nanoparticle targeting three oncogenes-<i>hTERT</i>, <i>BIRC5</i>, and <i>FGFR1</i>-key drivers of cancer progression. The gene discussed is FGFR1; the disease is cancer.